About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.